INSYS (INSY) Syndros Should Have Solid Uptake - Piper Jaffray

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. SPOT
6. BYD
7. BE
8. SPY
9. WCN
10. NDAQ

Go back to INSYS (INSY) Syndros Should Have Solid Uptake - Piper Jaffray

Insys Therapeutics Announces FDA Approval of Syndros™

July 5, 2016 6:55 AM EDT

PHOENIX, July 05, 2016 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (Insys or the Company) (NASDAQ: INSY) today announced that the U.S. Food and Drug Administration (FDA) has approved Insys dronabinol oral solution, SyndrosTM, an orally administered liquid formulation of the pharmaceutical cannabinoid dronabinol, a pharmaceutical version of tetrahydrocannabinol ("THC").  Syndros is approved for use in treating anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.  Syndros is currently awaiting scheduling by the U.S. Drug... More